SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) December 10, 1998
OSTEOTECH, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-19278 13-3357370
(State or other jurisdiction (Commission file Number) (IRS
of incorporation) Identification No.)
51 James Way, Eatontown, New Jersey 07724
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (732) 542-2800
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
The U.S. Patent and Trademark office has issued Osteotech, Inc. (the "Company")
U.S. Patent #5,846,484 entitled "Pressure Flow System and Method for Treating a
Fluid Permeable Workpiece Such As Bone" (the "Patent").
The Patent covers, among other things, methods to inactivate viruses in bone as
well as methods to impregnate bone with a variety of pharmacological agents,
such as antibiotics and growth factors. The Company already owns patents which
cover negative pressure flow systems.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: December 11, 1998
OSTEOTECH, INC.
----------------------------------------
(Registrant)
By: /s/ Michael J. Jeffries
----------------------------------
MICHAEL J. JEFFRIES
Executive Vice President,
Chief Operating Officer and
Chief Financial Officer
(Principal Financial Officer
and Principal Accounting Officer)
